Product Information

METHYLPHENIDATE 20 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.2102 per EA under NDC 43547048810. Its NADAC has been published 270 times since Jun 23, 2021.

FDA first approved this application on Jul 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 20 MG TABLET

Methylphenidate hydrochloride
$0.2102per EA
DEA Schedule CII

Strength

20 mg/1

NDC

43547048810

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212697

FDA Approved

7/23/2020

TE Code

AB

On Market Since

7/1/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 20 MG TABLET has been published 270 times since Jun 23, 2021, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2102 per EA
All-time high$0.2532 (Oct 16, 2024)
All-time low$0.1079 (Apr 17, 2024)
52-week high$0.2332
52-week low$0.1962
Median price$0.2024
Average price$0.1998
Largest weekly change+108.2% (Aug 21, 2024)
Weeks tracked270
Tracking sinceJun 23, 2021

Price History

1W

-0.5%

1M

-0.5%

3M

+4.2%

6M

-1.5%

1Y

-9.4%

3Y

+23.5%

5Y

-1.0%

All

+3.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.2102 per EA (NDC 43547048810), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG TABLET has risen 3.3%. It has been tracked across 270 weekly CMS publications since Jun 23, 2021.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG TABLET?

Since Jun 23, 2021, the NADAC for METHYLPHENIDATE 20 MG TABLET has ranged from a low of $0.1079 (Apr 17, 2024) to a high of $0.2532 (Oct 16, 2024), with a median of $0.2024 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 20 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METHYLPHENIDATE 20 MG TABLET?

METHYLPHENIDATE 20 MG TABLET (NDC 43547048810) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.